text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325604/2022

text: clinical

text: Baseline surveillance


status: PUBLIC

text: SARS-CoV-2: clinical or host-associated

tag: attribute

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: pda|emily.smith@theiagen.com

characteristic: INSDC center alias

text: pda|emily.smith@theiagen.com

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: CDPH VBL

text: USA: California

text: Homo sapiens

characteristic: host

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325605/2022

characteristic: isolate

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: Baseline surveillance

characteristic: title


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325606/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325608/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325610/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325611/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325621/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325623/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325625/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325629/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325631/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325640/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325642/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325644/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325647/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325649/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325655/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325659/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325663/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325668/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325669/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325675/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325676/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325685/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325686/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325688/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325689/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325691/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325699/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325702/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325705/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325707/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325711/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325712/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325714/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325717/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325720/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325721/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325722/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325723/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325726/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325727/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325731/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325741/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325745/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325748/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325752/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325756/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325759/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325760/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325764/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325769/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325773/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325777/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325778/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325782/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325785/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325787/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325788/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325794/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325818/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325820/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325823/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325835/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325836/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325857/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325859/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325872/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325888/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325894/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325907/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325912/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325919/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325924/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325935/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325936/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325937/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325938/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325939/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325942/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325944/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325945/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325947/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325949/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325952/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325954/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325955/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325957/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325963/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325967/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325971/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325975/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325991/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325997/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000325998/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326000/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326003/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326004/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326006/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326007/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326026/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326044/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326061/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326074/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326075/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326080/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326086/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326089/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326108/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326135/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326137/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326144/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326153/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326155/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326162/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326171/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326178/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326179/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326183/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326184/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326187/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326188/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326192/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326193/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326195/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326228/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326240/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326264/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326277/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326280/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326314/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326328/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326333/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326366/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326369/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326375/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326380/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326410/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326411/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326451/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326489/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326500/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326525/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326527/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326530/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326539/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326563/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326564/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326571/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326574/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326579/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326582/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326586/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326589/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326590/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326597/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326603/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326612/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326617/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326619/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326626/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326628/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326631/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326634/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326638/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326644/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326652/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326654/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326655/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326657/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326670/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326677/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326682/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326689/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326692/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326696/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326699/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326711/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326716/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326727/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326728/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326732/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326736/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326737/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326756/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326767/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326768/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326798/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326800/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326811/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326826/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326861/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326863/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326865/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326868/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326870/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326880/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326885/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326886/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326887/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326888/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326892/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326895/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326898/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326901/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326902/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326903/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326904/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326914/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326920/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326927/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326935/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326938/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326940/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326944/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326946/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326947/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326952/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326954/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326957/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326958/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326959/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326963/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326964/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326973/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326978/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326998/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327003/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327005/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327010/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327012/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327020/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327022/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327031/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327032/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327084/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327096/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327099/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327101/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327106/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327122/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327125/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327129/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327131/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327133/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327137/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327147/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327148/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327151/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327152/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327153/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327155/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327161/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327179/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327183/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327185/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327187/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327190/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327198/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327199/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327210/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327217/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327222/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327224/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327231/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327235/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327239/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327249/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327250/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327261/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327263/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327266/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327285/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327292/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327416/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327426/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327451/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327496/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327500/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327516/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327519/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327531/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327535/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327538/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327555/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327560/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327567/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327574/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327578/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327596/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327602/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327603/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327620/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327625/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327626/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327627/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327631/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327633/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327635/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327636/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327638/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327643/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327648/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327656/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327669/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327691/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327708/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327715/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327716/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327726/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327736/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327742/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327748/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327754/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327878/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327899/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327903/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327914/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327918/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327919/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327923/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327927/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327929/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327931/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327934/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance